KIT inhibitors (Blueprint Medicines Corporation/University of Miami/Dana Farber Cancer Institute)

N/A

Report date: 2025/06/11 11:14:43
NME

Base Information

Drug NameKIT inhibitors (Blueprint Medicines Corporation/University of Miami/Dana Farber Cancer Institute)
Drug Alias NameBLU-5675BLU-7444
ClassificationSmall molecules
Mechanisms of ActionStem cell growth factor receptor inhibitorsAnticancer protein kinase inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsGastrointestinal Stromal Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Miami
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteUniversity Of MiamiBlueprint Medicines Corp
Inactive CompaniesN/A
Active IndicationsGastrointestinal Stromal Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A